Hypertension: Covidien launches OneShot renal denervation sales in global markets

January 16, 2013 by MassDevice staff

Medical device maker launches commercial sales of its OneShot renal denervation system in Europe, Middle East, Africa, Asia and Latin America.

Covidien logo

Medical device maker Covidien (NYSE:COV) this week announced commercial launch of its OneShot renal denervation system in markets around the world, bringing the company up to speed with some of its renal denervation rivals.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp